CTI has disclosed its earnings forecast, estimating net profit attributable to the parent for the first half of 2026 at 561 million to 571 million yuan, representing a year-on-year increase of 20% to 22.12%. The company stated that its earlier investments in pharmaceuticals, medical devices, aviation materials, semiconductor chips, the low-altitude economy, PCB testing, new energy vehicles, and vehicle-to-everything have continued to grow, with investment returns gradually materializing and becoming a key driver of performance growth. Coordinated progress across all business segments has led to steady growth in operating results.
Centre Testing Intl ShenzhenCTI forecasts 20%-22.12% rise in first-half net profit, driven by investment returns and business growth.